TriNetX

TriNetX is a global network of healthcare organizations and life sciences companies driving real-world research to accelerate the development of new therapies. Founded in 2013 and headquartered in the United States, TriNetX offers a self-service, HIPAA, GDPR, and LGPD-compliant platform of federated EHR datasets and consulting partnerships. This approach puts the power of real-world data into the hands of its worldwide community to improve protocol design, streamline trial operations, refine safety signals, and enrich real-world evidence generation.

The company recently secured a $40.00M Series D investment on 13 March 2019, with participation from an impressive group of investors including MPM Capital, ITOCHU Technology Ventures, F2 Ventures, Itochu, Deerfield, Mitsui & Co, and the Merck Global Health Innovation Fund. With its focus on healthcare analytics, big data, and pharmaceutical innovation, TriNetX continues to be a noteworthy player in the industry.